May God heal the World.

Anyways, Are you interested in affiliate marketing or you need someone to guide and tutor you for free. Chat me up on... Zero Seven Zero Three Zero Zero Nine Five Nine One Nine

K

.

Sign up for any digital course today!
Become a pro in any area of freelancing and increase your chance of earning today!
Click on the link in my signature and sign up today!

Scamdemic

You have to be crazy to take their poison vaccine with this much info out now !!


⁣Brazilian Presenter Rafael Silva got his 3rd jab on Dec 28th, he collapsed live on air the other day. it has been reported that he had five heart attacks on the way to the hospital.
https://brandnewtube.com/v/BKhvOq

Dyt:
856 New COVID-19 Cases, 433 Discharged And 5 Deaths On January 5


https://m.facebook.com/story.php?story_fbid=287157966782511&id=100064649291568

Just 7 in Borno? When 5 tested positive in unit alone, when 13 people underwent PCR COVID-19 test.

Ok

Is Omicron real?

I hope they know the difference between died from Covid and died with Covid. Very Importanter...
Which method are they using for the testing when CDC has said new method is required no longer PCR.
The test must do good job to distinguish Influenza(Flu) and Covid.

From CDC website:
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.

[b][/b] YOU STILL THEY DO THIS THING